I believe that obtaining an adequate blood sample with minimal discomfort is more about technique than it is about the equipment.
The IDS team is challenging ourselves once a month to eat foods that are tough for people with type 1 diabetes to manage their blood sugars after consuming.
What I learned at the 2020 ADA Scientific Sessions by Gary Scheiner MS, CDE -Owner & Clinical Director of Integrated Diabetes Services. Read about the newest advances in Diabetes management.
It features everything that made the first two editions “essential reading” for everyone who takes insulin.
A very special client of ours, Deepak Malhotra, 44, recently recovered from a mild case of the coronavirus. He has lived with type 1 diabetes for 25 years and describes his story.
Pros & Cons of the Tandem t:slim with Control IQ Tandem t:slim with Control IQ: "Smahtah" than the average pump By Gary Scheiner MS, CDCES I’m a big [...]
I’m writing this with the hope that it will help your desire and motivation to increase your physical activity levels!
I first learned about the Eversense implanted continuous glucose sensor while attending the American Association of Diabetes Educators annual conference.
Here's a breakdown of what's on tap in the future...
Diabetes management, if limited to FDA recommendations is largely ineffective.
We've all heard about the "Keto Diet", but is it good for people with type 1 and type 2 diabetes? Get an unbiased breakdown from 2 Certified Diabetes Educators.
Have there been any documented deaths from waiting too long on hold with an insurance company? I may have come close a few times. The hold times can be anywhere from a lucky few minutes to my all-time record of 37 minutes. Speaking of, I am currently in minute 23 as I type.
Medtronic’s Hybrid Closed Loop System: Getting More Bang For Your Buck By, Gary Scheiner MS, CDE, Jennifer Smith RD, LD, CDE, Alicia Downs RN, MSN, CDE, Annette Valle RN, [...]
A recent study showed that the insulin users in North America make up 14% of all insulin users worldwide, but they account for nearly 50% of total world-wide sales. With so many profit-making avenues, you can see why this three-company oligopoly (Lilly, Novo Nordisk, Sanofi) is keen to keep raising insulin prices.
My dad is a mechanic, so I spent my formative years leaning over engines and climbing on car lifts getting covered in grease stains and rust. So it's probably no [...]